Cutting edge technology guarantees the highest quality of products produced at our state-of-the-art facility located in Pleasant Prairie, Wisconsin. Our three-story, 84,000 sq. ft., high-tech manufacturing facility is ground zero for establishing generic pharmaceutical manufacturing for the U.S.
Chief Scientific Officer
People-centric environment designed to create wellness and positive culture
Competitive salary and healthcare benefits for employees
$250M investment over 10 years
77 new local jobs by the end of 2022, 400+ jobs in total
Partnering with local universities for technical training
Green construction to reduce wastage
Installing Eco and energy friendly manufacturing equipment
Every day, clinicians wonder if they will have the necessary medicines to treat the patients that they serve. While the COVID-19 pandemic may have drawn attention to the importance of domestic drug manufacturing, this has been a priority of ours since our inception.
In 2019, our dream became a reality as we broke ground on the first project of its kind in the last 30 years, and in 2021, we opened doors to our state-of-the-art manufacturing facility located in Pleasant Prairie, Wisconsin. Commercial production is expected to commence in 2023.
We have invested over $100 million to build a pharmaceutical manufacturing facility in Pleasant Prairie, Wisconsin that will provide hospitals access to affordable critical need medication.
We've combined our expertise in development and manufacturing with advanced technological capabilities, innovative approaches, and business models to overcome development hurdles and